CWR22

Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma

Mark A. Wainstein, Feng He, Robinson D, Hsing-Jien Kung, Stuart Schwartz, Joseph M. Giaconia, Nancy L. Edgehouse, Theresa P. Pretlow, Donald R. Bodner, Elroy D. Kursh, Martin I. Resnick, Allen Seftel, Thomas G. Pretlow

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

The long-term propagation of primary human prostate cancer (PCA) in vivo or in vitro has been rare. Most such PC As are phenotypically different from most PCAs in humans; i.e., they make little prostate specific antigen and respond little, if at all, to androgen deprivation. A serially transplantable, primary human PCA, designated CWR22, exhibits a clonal cytogenetic aberration, causes high elevations of prostate specific antigen in the peripheral blood of nude mice, and is unusually responsive to androgen deprivation as compared with other xenografts. Studies of mRNA from CWR22 have demonstrated the expression of prostate specific antigen and the epidermal growth factor receptor family including erbB1/epidermal growth factor receptor, erbB2/neu, and erbB3, but not erbB4. A ligand for these receptors, the neu differentiation factor, is also expressed.

Original languageEnglish
Pages (from-to)6049-6052
Number of pages4
JournalCancer Research
Volume54
Issue number23
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Heterografts
Androgens
Carcinoma
Epidermal Growth Factor Receptor
Prostatic Neoplasms
Neuregulin-1
Passive Cutaneous Anaphylaxis
Nude Mice
Chromosome Aberrations
Ligands
Messenger RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Wainstein, M. A., He, F., D, R., Kung, H-J., Schwartz, S., Giaconia, J. M., ... Pretlow, T. G. (1994). CWR22: Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma. Cancer Research, 54(23), 6049-6052.

CWR22 : Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma. / Wainstein, Mark A.; He, Feng; D, Robinson; Kung, Hsing-Jien; Schwartz, Stuart; Giaconia, Joseph M.; Edgehouse, Nancy L.; Pretlow, Theresa P.; Bodner, Donald R.; Kursh, Elroy D.; Resnick, Martin I.; Seftel, Allen; Pretlow, Thomas G.

In: Cancer Research, Vol. 54, No. 23, 01.01.1994, p. 6049-6052.

Research output: Contribution to journalArticle

Wainstein, MA, He, F, D, R, Kung, H-J, Schwartz, S, Giaconia, JM, Edgehouse, NL, Pretlow, TP, Bodner, DR, Kursh, ED, Resnick, MI, Seftel, A & Pretlow, TG 1994, 'CWR22: Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma', Cancer Research, vol. 54, no. 23, pp. 6049-6052.
Wainstein MA, He F, D R, Kung H-J, Schwartz S, Giaconia JM et al. CWR22: Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma. Cancer Research. 1994 Jan 1;54(23):6049-6052.
Wainstein, Mark A. ; He, Feng ; D, Robinson ; Kung, Hsing-Jien ; Schwartz, Stuart ; Giaconia, Joseph M. ; Edgehouse, Nancy L. ; Pretlow, Theresa P. ; Bodner, Donald R. ; Kursh, Elroy D. ; Resnick, Martin I. ; Seftel, Allen ; Pretlow, Thomas G. / CWR22 : Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma. In: Cancer Research. 1994 ; Vol. 54, No. 23. pp. 6049-6052.
@article{e9585d7d4ccf47969ad9e62b3f8b1776,
title = "CWR22: Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma",
abstract = "The long-term propagation of primary human prostate cancer (PCA) in vivo or in vitro has been rare. Most such PC As are phenotypically different from most PCAs in humans; i.e., they make little prostate specific antigen and respond little, if at all, to androgen deprivation. A serially transplantable, primary human PCA, designated CWR22, exhibits a clonal cytogenetic aberration, causes high elevations of prostate specific antigen in the peripheral blood of nude mice, and is unusually responsive to androgen deprivation as compared with other xenografts. Studies of mRNA from CWR22 have demonstrated the expression of prostate specific antigen and the epidermal growth factor receptor family including erbB1/epidermal growth factor receptor, erbB2/neu, and erbB3, but not erbB4. A ligand for these receptors, the neu differentiation factor, is also expressed.",
author = "Wainstein, {Mark A.} and Feng He and Robinson D and Hsing-Jien Kung and Stuart Schwartz and Giaconia, {Joseph M.} and Edgehouse, {Nancy L.} and Pretlow, {Theresa P.} and Bodner, {Donald R.} and Kursh, {Elroy D.} and Resnick, {Martin I.} and Allen Seftel and Pretlow, {Thomas G.}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "54",
pages = "6049--6052",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - CWR22

T2 - Androgen-dependent Xenograft Model Derived from a Primary Human Prostatic Carcinoma

AU - Wainstein, Mark A.

AU - He, Feng

AU - D, Robinson

AU - Kung, Hsing-Jien

AU - Schwartz, Stuart

AU - Giaconia, Joseph M.

AU - Edgehouse, Nancy L.

AU - Pretlow, Theresa P.

AU - Bodner, Donald R.

AU - Kursh, Elroy D.

AU - Resnick, Martin I.

AU - Seftel, Allen

AU - Pretlow, Thomas G.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The long-term propagation of primary human prostate cancer (PCA) in vivo or in vitro has been rare. Most such PC As are phenotypically different from most PCAs in humans; i.e., they make little prostate specific antigen and respond little, if at all, to androgen deprivation. A serially transplantable, primary human PCA, designated CWR22, exhibits a clonal cytogenetic aberration, causes high elevations of prostate specific antigen in the peripheral blood of nude mice, and is unusually responsive to androgen deprivation as compared with other xenografts. Studies of mRNA from CWR22 have demonstrated the expression of prostate specific antigen and the epidermal growth factor receptor family including erbB1/epidermal growth factor receptor, erbB2/neu, and erbB3, but not erbB4. A ligand for these receptors, the neu differentiation factor, is also expressed.

AB - The long-term propagation of primary human prostate cancer (PCA) in vivo or in vitro has been rare. Most such PC As are phenotypically different from most PCAs in humans; i.e., they make little prostate specific antigen and respond little, if at all, to androgen deprivation. A serially transplantable, primary human PCA, designated CWR22, exhibits a clonal cytogenetic aberration, causes high elevations of prostate specific antigen in the peripheral blood of nude mice, and is unusually responsive to androgen deprivation as compared with other xenografts. Studies of mRNA from CWR22 have demonstrated the expression of prostate specific antigen and the epidermal growth factor receptor family including erbB1/epidermal growth factor receptor, erbB2/neu, and erbB3, but not erbB4. A ligand for these receptors, the neu differentiation factor, is also expressed.

UR - http://www.scopus.com/inward/record.url?scp=0028053632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028053632&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 6049

EP - 6052

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 23

ER -